Ownership Summary
The institutional landscape for BioNexus Gene Lab Corp (NASDAQ:BGLC) includes 2 filers as of the latest reporting cycle ending September 2025.
- Institutional ownership in BioNexus Gene Lab edged up to 1.2% in September 2025, compared to 0.5% in June 2025.
- In percentage terms, this reflects as a holdings change of 132.97% quarter on quarter, and a decrease of 60.00% year over year.
- A review of institutional activity for BioNexus Gene Lab shows 1 of 2 filers increasing their positions, while 1 reduced their stake, and 0 remained unchanged.
- The aggregate institutional position in BioNexus Gene Lab now stands at 22.28K shares as of September 2025, after investors increased their holdings (up by 12.71K shares quarter on quarter which is down 108.06K shares year over year).
- As of September 30, 2025, DRW Securities, LLC held BioNexus Gene Lab's largest shareholding position with over 14.65K shares, representing 0.82% of total outstanding shares.
- Among the most significant buyers of BioNexus Gene Lab during September 2025 were DRW Securities, LLC (14.65K).
- Leading sellers of BioNexus Gene Lab stock in September 2025 included UBS Group AG (1.94K).
- The top 2 institutional holders of BioNexus Gene Lab for the quarter ending September 2025 included DRW Securities, LLC (14.65K), UBS Group AG (7.63K).